Concepedia

T. Twaddell

TT

Statistics

Publications

4

Citations

2.8K

H-Index

4

Active since

1996

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

T. Twaddell is an author at Memorial Sloan Kettering Cancer Center specializing in oncology, medicine, and pharmacology.

Publications per year

1996–2000

4

Publications

4

Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer.

José Baselga, Debu Tripathy, John Mendelsohn et al. · Journal of Clinical Oncology · 1996 · 1.4K citations

, , +17

Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment.

Mark D. Pegram, A. Lipton, Daniel F. Hayes et al. · Journal of Clinical Oncology · 1998 · 1.1K citations

, , +17

Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer.

José Baselga, Debu Tripathy, J. Mendelsohn et al. · PubMed · 1999 · 300 citations

, , +16

Phase I Assessment of the Pharmacokinetics, Metabolism, and Safety of Emitefur in Patients With Refractory Solid Tumors

John Nemunaitis, Rob Eager, T. Twaddell et al. · Journal of Clinical Oncology · 2000 · 20 citations

, , +14

1–4 of 4